{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T18:03:22Z","timestamp":1791655402133,"version":"4.3.4"},"reference-count":59,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aaojournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ophtha.2026.04.034","type":"journal-article","created":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T15:01:52Z","timestamp":1777993312000},"page":"1257-1275","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Diagnostic Accuracy and Complementary Value of Biomarkers for Primary Vitreoretinal Lymphoma"],"prefix":"10.1016","volume":"133","author":[{"given":"Yuchen","family":"Lou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenxiao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongrui","family":"Chai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinlong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.ophtha.2026.04.034_bib1","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1634\/theoncologist.2011-0210","article-title":"Primary vitreoretinal lymphoma: a report from an International Primary Central Nervous System Lymphoma Collaborative Group symposium","volume":"16","author":"Chan","year":"2011","journal-title":"Oncologist"},{"issue":"17","key":"10.1016\/j.ophtha.2026.04.034_bib2","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1182\/blood.2020008235","article-title":"Primary vitreoretinal lymphoma: a diagnostic and management challenge","volume":"138","author":"Soussain","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.ophtha.2026.04.034_bib3","doi-asserted-by":"crossref","first-page":"808511","DOI":"10.3389\/fonc.2022.808511","article-title":"Clinical features, diagnosis, management and prognosis of primary intraocular lymphoma","volume":"12","author":"Zhao","year":"2022","journal-title":"Front Oncol"},{"issue":"2","key":"10.1016\/j.ophtha.2026.04.034_bib4","doi-asserted-by":"crossref","first-page":"69","DOI":"10.21873\/cdp.10010","article-title":"Clinical features of primary vitreoretinal lymphoma: a single-center study","volume":"1","author":"Kase","year":"2021","journal-title":"Cancer Diagn Progn"},{"issue":"9","key":"10.1016\/j.ophtha.2026.04.034_bib5","first-page":"1762","article-title":"Primary intraocular lymphoma: clinical, cytologic, and flow cytometric analysis","volume":"111","author":"Zaldivar","year":"2004","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.ophtha.2026.04.034_bib6","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.ajo.2005.05.032","article-title":"Diagnostic testing of vitrectomy specimens","volume":"140","author":"Davis","year":"2005","journal-title":"Am J Ophthalmol"},{"issue":"7","key":"10.1016\/j.ophtha.2026.04.034_bib7","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.1167\/iovs.06-0031","article-title":"IL-10 measurement in aqueous humor for screening patients with suspicion of primary intraocular lymphoma","volume":"48","author":"Cassoux","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2-3","key":"10.1016\/j.ophtha.2026.04.034_bib8","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s12026-011-8262-6","article-title":"Interleukin 10 in the tumor microenvironment: a target for anticancer immunotherapy","volume":"51","author":"Sato","year":"2011","journal-title":"Immunol Res"},{"issue":"14","key":"10.1016\/j.ophtha.2026.04.034_bib9","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1167\/iovs.64.14.27","article-title":"Next-generation sequencing of vitreoretinal lymphoma by vitreous liquid biopsy: diagnostic potential and genotype\/phenotype correlation","volume":"64","author":"Kwak","year":"2023","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.ophtha.2026.04.034_bib10","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1182\/blood-2015-01-620518","article-title":"High frequency of MYD88 mutations in vitreoretinal B-cell lymphoma: a valuable tool to improve diagnostic yield of vitreous aspirates","volume":"126","author":"Bonzheim","year":"2015","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.ophtha.2026.04.034_bib11","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s13045-022-01356-7","article-title":"Evidence-based expert consensus on the management of primary central nervous system lymphoma in China","volume":"15","author":"Chen","year":"2022","journal-title":"J Hematol Oncol"},{"issue":"1","key":"10.1016\/j.ophtha.2026.04.034_bib12","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s40662-025-00434-4","article-title":"Clinical guidelines for the diagnosis and treatment of vitreoretinal lymphoma in Chinese patients (2024)","volume":"12","author":"Zhang","year":"2025","journal-title":"Eye Vis (Lond)"},{"issue":"8","key":"10.1016\/j.ophtha.2026.04.034_bib13","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","article-title":"QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies","volume":"155","author":"Whiting","year":"2011","journal-title":"Ann Intern Med"},{"issue":"11","key":"10.1016\/j.ophtha.2026.04.034_bib14","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.7326\/M21-2234","article-title":"QUADAS-C: a tool for assessing risk of bias in comparative diagnostic accuracy studies","volume":"174","author":"Yang","year":"2021","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.ophtha.2026.04.034_bib15","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.ajo.2013.11.002","article-title":"Neoplastic masquerade syndromes in patients with uveitis","volume":"157","author":"Grange","year":"2014","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"10.1016\/j.ophtha.2026.04.034_bib16","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/S0161-6420(00)00499-1","article-title":"Uveitis masquerade syndromes","volume":"108","author":"Rothova","year":"2001","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.ophtha.2026.04.034_bib17","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/aos.14993","article-title":"Vitreous proteomics, a gateway to improved understanding and stratification of diverse uveitis aetiologies","volume":"100","author":"Schrijver","year":"2022","journal-title":"Acta Ophthalmol"},{"issue":"7","key":"10.1016\/j.ophtha.2026.04.034_bib18","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.ophtha.2020.01.042","article-title":"Logistic regression classification of primary vitreoretinal lymphoma versus uveitis by interleukin 6 and interleukin 10 levels","volume":"127","author":"Kuo","year":"2020","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.ophtha.2026.04.034_bib19","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/aos.14036","article-title":"Combined cellular and soluble mediator analysis for improved diagnosis of vitreoretinal lymphoma","volume":"97","author":"de Hoog","year":"2019","journal-title":"Acta Ophthalmol"},{"issue":"4","key":"10.1016\/j.ophtha.2026.04.034_bib20","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1097\/IAE.0000000000002319","article-title":"MYD88 L265P mutation detection in the aqueous humor of patients with vitreoretinal lymphoma","volume":"39","author":"Miserocchi","year":"2019","journal-title":"Retina"},{"issue":"12","key":"10.1016\/j.ophtha.2026.04.034_bib21","doi-asserted-by":"crossref","first-page":"5235","DOI":"10.1167\/iovs.03-0035","article-title":"Characterization of vitreous B-cell infiltrates in patients with primary ocular lymphoma, using CDR3 size polymorphism analysis of antibody transcripts","volume":"44","author":"Gorochov","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"10.1016\/j.ophtha.2026.04.034_bib22","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.oret.2022.08.005","article-title":"Aqueous humor-derived MYD88 L265P mutation analysis in vitreoretinal lymphoma: a potential less invasive method for diagnosis and treatment response assessment","volume":"7","author":"Demirci","year":"2023","journal-title":"Ophthalmol Retina"},{"issue":"12","key":"10.1016\/j.ophtha.2026.04.034_bib23","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.18240\/ijo.2022.12.01","article-title":"Clinical utility of cytokine analysis in the diagnosis and efficacy monitoring of vitreoretinal lymphoma","volume":"15","author":"Kang","year":"2022","journal-title":"Int J Ophthalmol"},{"issue":"6","key":"10.1016\/j.ophtha.2026.04.034_bib24","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1371\/journal.pone.0065627","article-title":"Effect of intravitreal methotrexate and rituximab on interleukin-10 levels in aqueous humor of treated eyes with vitreoretinal lymphoma","volume":"8","author":"Raja","year":"2013","journal-title":"PloS One"},{"issue":"8","key":"10.1016\/j.ophtha.2026.04.034_bib25","first-page":"41","article-title":"Vitreous body cell free DNA sequencing as a reliable method for vitreoretinal lymphoma diagnostics","volume":"66","author":"Heissigerova","year":"2025","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"10.1016\/j.ophtha.2026.04.034_bib26","first-page":"359","article-title":"[Diagnostic value of interleukin-10 and interleukin-6 in the vitreous of intraocular malignant lymphoma patients]","volume":"108","author":"Hirakata","year":"2004","journal-title":"Nippon Ganka Gakkai Zasshi"},{"issue":"7","key":"10.1016\/j.ophtha.2026.04.034_bib27","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/pin.12551","article-title":"Cytopathologic findings of cell block materials from the vitreous: diagnostic distinction between intraocular lymphoma and non-lymphomatous diseases","volume":"67","author":"Kanno-Okada","year":"2017","journal-title":"Pathol Int"},{"issue":"1","key":"10.1016\/j.ophtha.2026.04.034_bib28","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1038\/s41598-020-59666-0","article-title":"Analysis of inflammatory mediators in the vitreous humor of eyes with pan-uveitis according to aetiological classification","volume":"10","author":"Fukunaga","year":"2020","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.ophtha.2026.04.034_bib29","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/ejh.13191","article-title":"CD79B mutations in primary vitreoretinal lymphoma: diagnostic and prognostic potential","volume":"102","author":"Yonese","year":"2019","journal-title":"Eur J Haematol"},{"issue":"5","key":"10.1016\/j.ophtha.2026.04.034_bib30","first-page":"1598","article-title":"The molecular hallmarks of primary and secondary vitreoretinal lymphoma","volume":"6","author":"Bonzheim","year":"2022","journal-title":"Blood Adv"},{"issue":"3","key":"10.1016\/j.ophtha.2026.04.034_bib31","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.ajo.2013.12.014","article-title":"Distinct microRNA-155 expression in the vitreous of patients with primary vitreoretinal lymphoma and uveitis","volume":"157","author":"Tuo","year":"2014","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ophtha.2026.04.034_bib32","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3109\/09273948.2012.752507","article-title":"Vitreoretinal lymphoma versus uveitis: cytokine profile and correlations","volume":"22","author":"Caraballo","year":"2014","journal-title":"Ocul Immunol Inflamm"},{"issue":"6","key":"10.1016\/j.ophtha.2026.04.034_bib33","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1097\/IAE.0000000000002127","article-title":"Differential diagnosis for vitreoretinal lymphoma with vitreoretinal findings, immunoglobulin clonality tests, and interleukin levels","volume":"39","author":"Lee","year":"2019","journal-title":"Retina"},{"key":"10.1016\/j.ophtha.2026.04.034_bib34","article-title":"Cell-free DNA sequencing of intraocular fluid as liquid biopsy in the diagnosis of vitreoretinal lymphoma","volume":"12","author":"Gu","year":"2022","journal-title":"Front Oncol"},{"issue":"10","key":"10.1016\/j.ophtha.2026.04.034_bib35","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1001\/jamaophthalmol.2018.2887","article-title":"Potential diagnosis of vitreoretinal lymphoma by detection of MYD88 mutation in aqueous humor with ultrasensitive droplet digital polymerase chain reaction","volume":"136","author":"Hiemcke-Jiwa","year":"2018","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.ophtha.2026.04.034_bib36","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ajo.2021.09.032","article-title":"Vitreoretinal lymphoma: optimizing diagnostic yield and accuracy","volume":"236","author":"Santos","year":"2022","journal-title":"Am J Ophthalmol"},{"issue":"10","key":"10.1016\/j.ophtha.2026.04.034_bib37","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.4103\/ijo.IJO_1712_19","article-title":"MYD88 L265P mutation in intraocular lymphoma: a potential diagnostic marker","volume":"68","author":"Narasimhan","year":"2020","journal-title":"Indian J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ophtha.2026.04.034_bib38","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.oret.2024.12.010","article-title":"Cell-free DNA from aqueous and dilute vitreous improves detection of vitreoretinal lymphoma","volume":"9","author":"Brown","year":"2025","journal-title":"Ophthalmol Retina"},{"issue":"3","key":"10.1016\/j.ophtha.2026.04.034_bib39","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1080\/09273940802702553","article-title":"Cytokine and molecular analyses of intraocular lymphoma","volume":"17","author":"Ohta","year":"2009","journal-title":"Ocul Immunol Inflamm"},{"issue":"4","key":"10.1016\/j.ophtha.2026.04.034_bib40","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1097\/IAE.0000000000001922","article-title":"Use of a threshold of interleukin-10 and IL-10\/IL-6 ratio in ocular samples for the screening of vitreoretinal lymphoma","volume":"38","author":"Pochat-Cotilloux","year":"2018","journal-title":"Retina"},{"issue":"9","key":"10.1016\/j.ophtha.2026.04.034_bib41","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1001\/archopht.1997.01100160327010","article-title":"Association of interleukin 10 in the vitreous and cerebrospinal fluid and primary central nervous system lymphoma","volume":"115","author":"Whitcup","year":"1997","journal-title":"Arch Ophthalmol"},{"issue":"10","key":"10.1016\/j.ophtha.2026.04.034_bib42","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.24689","article-title":"Logistic regression models of cytokines in differentiating vitreoretinal lymphoma from uveitis","volume":"36","author":"Tian","year":"2022","journal-title":"J Clin Lab Anal"},{"issue":"6","key":"10.1016\/j.ophtha.2026.04.034_bib43","doi-asserted-by":"crossref","first-page":"e668","DOI":"10.1111\/aos.14347","article-title":"The importance of cytokines analysis in the diagnosis of vitreoretinal lymphoma","volume":"98","author":"Frenkel","year":"2020","journal-title":"Acta Ophthalmol"},{"issue":"7","key":"10.1016\/j.ophtha.2026.04.034_bib44","first-page":"35","article-title":"Intraocular lymphoma: biomarkers revisited","volume":"61","author":"Sharma","year":"2020","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"10.1016\/j.ophtha.2026.04.034_bib45","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s10384-009-0662-y","article-title":"Diagnosis of intraocular lymphoma by polymerase chain reaction analysis and cytokine profiling of the vitreous fluid","volume":"53","author":"Sugita","year":"2009","journal-title":"Jpn J Ophthalmol"},{"issue":"2","key":"10.1016\/j.ophtha.2026.04.034_bib46","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1371\/journal.pone.0052385","article-title":"Cytokine profile in human eyes: contribution of a new cytokine combination for differential diagnosis between intraocular lymphoma or uveitis","volume":"8","author":"Fisson","year":"2013","journal-title":"PloS One"},{"issue":"6","key":"10.1016\/j.ophtha.2026.04.034_bib47","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1080\/09273948.2021.1873394","article-title":"More accurate diagnosis of vitreoretinal lymphoma using a combination of diagnostic test results: a prospective observational study","volume":"30","author":"Tanaka","year":"2022","journal-title":"Ocul Immunol Inflamm"},{"issue":"7","key":"10.1016\/j.ophtha.2026.04.034_bib48","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.ophtha.2020.11.018","article-title":"Single B-cell genomic analyses differentiate vitreoretinal lymphoma from chronic inflammation","volume":"128","author":"Tan","year":"2021","journal-title":"Ophthalmology"},{"issue":"7","key":"10.1016\/j.ophtha.2026.04.034_bib49","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1080\/09273948.2023.2173242","article-title":"Development of diagnostic recommendations for vitreoretinal lymphoma","volume":"32","author":"Zhang","year":"2024","journal-title":"Ocul Immunol Inflamm"},{"issue":"11","key":"10.1016\/j.ophtha.2026.04.034_bib50","first-page":"1217","article-title":"Diagnostic value of genetic mutation analysis and mutation profiling of cfDNA in intraocular fluid for vitreoretinal lymphoma, Cancer Commun (Lond)","volume":"42","author":"Chen","year":"2022"},{"issue":"7","key":"10.1016\/j.ophtha.2026.04.034_bib51","first-page":"1162","article-title":"Analysis of the diagnostic value of gene rearrangement detection combined with vitreous fluid IL-10 and IL-6 cytokine detection for primary intraocular lymphoma","volume":"21","author":"Lyu","year":"2021","journal-title":"Int Eye Sci"},{"issue":"9","key":"10.1016\/j.ophtha.2026.04.034_bib52","doi-asserted-by":"crossref","first-page":"5684","DOI":"10.3390\/ijms12095684","article-title":"Molecular biomarkers for the diagnosis of primary vitreoretinal lymphoma","volume":"12","author":"Wang","year":"2011","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ophtha.2026.04.034_bib53","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.955080","article-title":"Circulating cell-free DNA and IL-10 from cerebrospinal fluids aid primary vitreoretinal lymphoma diagnosis","volume":"12","author":"Zhuang","year":"2022","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.ophtha.2026.04.034_bib54","doi-asserted-by":"crossref","first-page":"12","DOI":"10.6004\/jnccn.2023.0002","article-title":"NCCN Guidelines\u00ae insights: central nervous system cancers, version 2.2022","volume":"21","author":"Horbinski","year":"2023","journal-title":"J Natl Compr Canc Netw"},{"issue":"15","key":"10.1016\/j.ophtha.2026.04.034_bib55","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1056\/NEJMoa1801445","article-title":"Genetics and pathogenesis of diffuse large B-cell lymphoma","volume":"378","author":"Schmitz","year":"2018","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.ophtha.2026.04.034_bib56","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1586\/14737159.2014.933075","article-title":"Molecular diagnostics clinical utility strategy: a six-part framework","volume":"14","author":"Frueh","year":"2014","journal-title":"Expert Rev Mol Diagn"},{"key":"10.1016\/j.ophtha.2026.04.034_bib57","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13000-016-0479-1","article-title":"Diagnostic efficacy of cell block method for vitreoretinal lymphoma","volume":"11","author":"Kase","year":"2016","journal-title":"Diagn Pathol"},{"issue":"4","key":"10.1016\/j.ophtha.2026.04.034_bib58","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1111\/cas.14347","article-title":"Gene expression profiling of primary vitreoretinal lymphoma","volume":"111","author":"Arai","year":"2020","journal-title":"Cancer Sci"},{"issue":"1","key":"10.1016\/j.ophtha.2026.04.034_bib59","article-title":"A noninvasive machine learning model using a complete blood count for screening of primary vitreoretinal lymphoma","volume":"16","author":"Li","year":"2025","journal-title":"Nat Commun"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642026003052?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642026003052?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T09:29:23Z","timestamp":1789723763000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642026003052"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":59,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S0161642026003052"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2026.04.034","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnostic Accuracy and Complementary Value of Biomarkers for Primary Vitreoretinal Lymphoma","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2026.04.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Academy of Ophthalmology, Inc. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}